Publication:
Successful Adaptation of Bee Venom Immunotherapy in a Patient Monosensitized to Api m 10.

Simple item page
dc.contributor.authorRuiz-Leon, B
dc.contributor.authorNavas, A
dc.contributor.authorSerrano, P
dc.contributor.authorEspinazo, M
dc.contributor.authorLabrador-Horrillo, M
dc.contributor.authorMonsalve, R I
dc.contributor.authorJurado, A
dc.contributor.authorMoreno-Aguilar, C
dc.contributor.funderSpanish Health Ministry
dc.contributor.funderCarlos III Health Institute
dc.contributor.funderSpanish Society of Allergology and Clinical Immunology
dc.contributor.funderAndalusian Society of Allergology and Clinical Immunology
dc.date.accessioned2023-02-08T14:42:04Z
dc.date.available2023-02-08T14:42:04Z
dc.date.issued2020-02-25
dc.description.abstractBee venom immunotherapy (BVIT), although highly effective, does not protect 10%-15% of patients allergic to bee stings [1]. Even though the production of allergenic extracts is standardized, the real content of major components is not completely known, given the total content of allergenic proteins and the enzymatic activity of phospholipase A2 (Api m 1) and hyaluronidase (Api m 2). To date, 12 allergens have been described as components of Apis mellifera venom (AMV). Api m 1, Api m 2, Api m 3, Api m 5, and Api m 10 are considered major allergens, and their specific IgE (sIgE) can be determined using commercially available techniques [1].
dc.identifier.citationRuiz-León B, Navas A, Serrano P, Espinazo M, Labrador-Horrillo M, Monsalve RI, et al. Successful Adaptation of Bee Venom Immunotherapy in a Patient Monosensitized to Api m 10. J Investig Allergol Clin Immunol. 2020;30(4):296-298
dc.identifier.doi10.18176/jiaci.0498
dc.identifier.issn1018-9068
dc.identifier.pmid32101173
dc.identifier.unpaywallURLhttp://www.jiaci.org/revistas/doi10.18176_jiaci.0498-suppl-figure_1.pdf
dc.identifier.urihttp://hdl.handle.net/10668/15163
dc.issue.number4
dc.journal.titleJournal of investigational allergology & clinical immunology
dc.journal.titleabbreviationJ Investig Allergol Clin Immunol
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number296-298
dc.provenanceRealizada la curación de contenido 05/09/2024
dc.publisherEsmon Publicidad
dc.pubmedtypeCase Reports
dc.pubmedtypeJournal Article
dc.relation.projectIDPI1502170
dc.relation.publisherversionhttps://www.jiaci.org/summary/vol30-issue4-num2063
dc.rights.accessRightsopen access
dc.subjectApi m 10
dc.subjectBee venom allergy
dc.subjectEffectiveness of venom immunotherapy
dc.subjectMolecular diagnosis
dc.subject.decsAlérgenos
dc.subject.decsApicultura
dc.subject.decsDesensibilización inmunológica
dc.subject.decsExposición profesional
dc.subject.decsHipersensibilidad
dc.subject.decsInmunización
dc.subject.decsInmunoglobulina E
dc.subject.decsMordeduras y picaduras de insectos
dc.subject.meshAllergens
dc.subject.meshBasophil Degranulation Test
dc.subject.meshBee Venoms
dc.subject.meshBeekeeping
dc.subject.meshDesensitization, Immunologic
dc.subject.meshHumans
dc.subject.meshHypersensitivity
dc.subject.meshImmune Tolerance
dc.subject.meshImmunization
dc.subject.meshImmunoglobulin E
dc.subject.meshInsect Bites and Stings
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshOccupational Exposure
dc.titleSuccessful Adaptation of Bee Venom Immunotherapy in a Patient Monosensitized to Api m 10.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number30
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Reina Sofía
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía